
Aviir, Inc. offers diagnostic tech for cardiovascular disease prevention and management, including wellness assessments.
Aviir, Inc., founded with a mission to revolutionize cardiovascular disease prevention and management, specializes in diagnostic technology. The company provides a range of cardiometabolic tests and services aimed at assessing and mitigating the risk of cardiovascular diseases. Their offerings include comprehensive wellness assessments that cover metabolic, thyroid, lipid profiles, and other critical blood chemistries, alongside specialized cardiovascular disease risk assessments and cardiometabolic syndrome diagnoses.
Notable figures affiliated with Aviir include leading experts in cardiology and metabolic health, contributing to the company's robust scientific foundation. Aviir has garnered attention from prominent investors in the healthcare sector, bolstering its research and development capabilities. The company's key achievements include the development of advanced diagnostic tools that have significantly impacted patient outcomes by enabling early detection and personalized management of cardiovascular conditions. Through its innovative approach, Aviir has made substantial contributions to the field of preventive cardiology.

Avicena
avicenaheart.com

Arterial Health International

Akrivis Technologies
akrivis.com

Cardiovip

Avidhrt
avidhrt.com

Avia
aviahealth.com

Avant Diagnostics

Iverson Genetic Diagnostics

Avails Medical
availsmedical.com

Avior Bio

Accelevir Diagnostics

InVision Medical Technology

ThromboVision

InvisionHeart
invisionheart.com

Vital Metrix
Companies similar to Aviir include Avicena, Arterial Health International, Akrivis Technologies and Cardiovip.
Aviir was founded in 2005.
Aviir's headquarters is located in Irvine, CA, US.
Aviir's most recent funding round was for $10M (USD) in June 2013.
As of Jun 21, 2013, Aviir has raised a total of $69.9M (USD).
Aviir has 75 employees as of Feb 5, 2024.